⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9608903 | 0.83 | PIM1 (0.30) | — | |
| SCHEMBL13455536 | 0.83 | PIM1 (0.30) | — | |
| SCHEMBL13455415 | 0.83 | PIM1 (0.30) | — | |
| SCHEMBL3215508 | 0.81 | PIM1 (0.32) | — | |
| SCHEMBL3219048 | 0.81 | PIM1 (0.32) | — | |
| SCHEMBL17230344 | 0.81 | PIM1 (0.32) | — | |
| SCHEMBL3203794 | 0.81 | PIM1 (0.32) | — | |
| SCHEMBL17230343 | 0.81 | PIM1 (0.32) | — | |
| SCHEMBL3211798 | 0.81 | PIM1 (0.32) | — | |
| SCHEMBL9607195 | 0.79 | PIM1 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8329732-B2 | Kinase inhibitors and methods of their use | NOVARTIS AG (CH) | 2012-12-11 | — | — | US | disclosed |
| US-20100056576-A1 | Kinase inhibitors and methods of their use | NOVARTIS AG (CH) | 2010-03-04 | — | — | US | disclosed |